11055 related articles for article (PubMed ID: 1450671)
1. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
[TBL] [Abstract][Full Text] [Related]
2. 4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.
Ishiwata K; Ido T; Honda C; Kawamura M; Ichihashi M; Mishima Y
Int J Rad Appl Instrum B; 1992 Apr; 19(3):311-8. PubMed ID: 1629021
[TBL] [Abstract][Full Text] [Related]
3. 4-Borono-2-
Ishiwata K
Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive estimation of
Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
6. Similar T/N ratio between
Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy.
Ishiwata K; Ido T; Mejia AA; Ichihashi M; Mishima Y
Int J Rad Appl Instrum A; 1991; 42(4):325-8. PubMed ID: 1850716
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
11. Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
Kubota R; Yamada S; Ishiwata K; Tada M; Ido T; Kubota K
Br J Cancer; 1993 Apr; 67(4):701-5. PubMed ID: 8471428
[TBL] [Abstract][Full Text] [Related]
12. 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.
Ishiwata K; Ido T; Kawamura M; Kubota K; Ichihashi M; Mishima Y
Int J Rad Appl Instrum B; 1991; 18(7):745-51. PubMed ID: 1787083
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the total distribution volume of
Romanov V; Isohashi K; Alobthani G; Beshr R; Horitsugi G; Kanai Y; Naka S; Watabe T; Shimosegawa E; Hatazawa J
Ann Nucl Med; 2020 Mar; 34(3):155-162. PubMed ID: 31808134
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
[TBL] [Abstract][Full Text] [Related]
15. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS
Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1833-41. PubMed ID: 9717809
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
Imahori Y; Ueda S; Ohmori Y; Kusuki T; Ono K; Fujii R; Ido T
J Nucl Med; 1998 Feb; 39(2):325-33. PubMed ID: 9476945
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]